| Title | Surveillance of health care associated infections in patients after coronary artery bypass graft surgery | |
| Authors | Kiriaki Roulia and Eleni Apostolopoulou
Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Hellas |
|
| Citation | Roulia, K., Apostolopoulou, E.: Surveillance of health care associated infections in patients after coronary artery bypass graft surgery, Epitheorese Klin. Farmakol. Farmakokinet. 24(1): 25-30 (2010) | |
| Publication Date | Accepted for publication (Final Version): April 10, 2010 | |
| Full Text Language | English | |
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)
pharmakonpress[at]pharmakonpress[.]gr |
|
| Keywords | Health care associated infections, coronary artery bypass grafting, complications, risk factors, surgical wound, infection control, prevention. | |
| Other Terms | review article | |
| Summary | A retrospective survey was performed to determine the incidence rate and incidence density rate, and to identify the risk factors associated with Healthcare Associated Infections (HAIs) after coronary artery bypass graft (CABG) within 30 days. The study occurred during a two-month period in a cardiac surgery center in Athens, Greece, that is a referral center for patients with cardiovascular diseases. All patients undergoing CABG surgery were selected for this investigation. A standardized Surveillance system based on the National Nosocomial Infections Surveillance (NNIS) of the Centers for Disease Control and Prevention (CDC) was implemented. The study included 136 patients (1331 patient-days). Among the 136 patients, 36 (26.5%) had in total 50 HAIs (36.8%). Among the 36 patients with HAIs, 28 (77.8) had a single infection, 8 (22.2%) had two infections. The majority of SSIs (90.5) on the leg and sternal site was diagnosed after discharge from hospital. The incidence rate of HAIs was 36.8% and the incidence density of HAIs was 37.6 infections per 1000 patient-days. The incidence rate of SSI at the leg was 12.5%, blood stream infection 8.1%, respiratory tract infection and urinary tract infection 6.6% and sternal site infection 2.9%. The incidence density of SSI at the leg was 12.8 infections per 1000 patient-days, blood stream infection 8.7 per 1000 patient-days, respiratory tract infection and urinary tract infection 6.8 infections per 1000 patient-days, and sternal site infection 3 infections per 1000 patient-days. A multivariate model showed that only two risk factors were significantly and independently responsible for HAIs after CABG surgery: Diabetes (AOR 1.781, 95% CI 1.240-2.551, P=0.002), and Peripheral vascular disease (AOR 1.642, 95% CI 1.161-2.332, P=0.005). These results show that the factors that had most influence on the development of HAIs after CABG surgery were patient related factors. | |
| References | 1. Eagle K.A., Guyton S.A., Davidoff R., et al.: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American Congress of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). American Heart Association Web site. Available Accessed September (2005) at: http://www.americanheart.org/presenter.jhtml.dentifier=9181
2. Vorisalo S., Haukipuro K., Pokela R., Syrjala H.: Risk features for surgical-site infections in coronary artery bypass surgery. Infect. Control. Hosp. Epidemiol. 19: 240-247 (1998) 3. Harington G., Russo P., Spelman D., et al.: Surgical-site infections rates and risk factor analysis in coronary artery bypass graft surgery. Infect. Control. Hosp. Epidemiol. 25: 472-476 (2004) 4. Paletta C., Huang D., Fiore A., et al.: Major leg wound complications after saphenous vein harvest for coronary revascularization. Ann. Thorac. Surg. 70: 492-50 (2000) 5. Olsen M., Sundi T., Lawton J., Damiano R., et al.: Risk factors for leg harvest surgical site infections after coronary artery bypass graft Surgery. J. Thorac. Cardiovasc. Surg. 126: 992-99 (2003) 6. Garland R., Frizelle E., Dobbs B., Singh H.: A retrospective audit of long-term lower limb complications following leg vein harvesting for coronary artery bypass grafting. Eur. J. Cardiothorac. Surg. 23: 950-955 (2003) 7. Swenne C., Lindholm C., Borowiec J., Carisson M.: Surgical-site infections within 60 days of coronary artery bypass graft surgery. J. Hosp. Infect. 57: 14-24 (2004) 8. Chelemer S., Prato S., Cox P., et al.: Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann. Thorac. Surg. 73: 138-142 (2002) 9. Russo P., Spelman D.: A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect. Control. Hosp. Epidemiol. 23: 372-376 (2002) 10. Olsen M., Lock-Buckery P., Hopkins D., et al.: The risk factors for deep and superficial chest Surgical site infections after coronary artery bypass graft surgery are different. J. Thorac. Cardiovasc. Surg. 124: 136-145 (2002) 11. Loop F.D., Lytle B.W., Cosgrove D.M., et al.: Sternal wound complications after isolated coronary artery bypass grafting early and late mortality, morbidity, and cost of care. Ann. Thorac. Surg. 119: 108-114 (1990) 12. Trick W., Scheckler W., Tokars J., et al.: Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. Ann. Thorac. Surg. 119: 108-114 (2000) 13. Tegnell A., Aren C., Ohman L.: Coagulasenegative staphylococcal and sternal infections after cardiac operation. Ann. Thorac. Surg. 69: 1104-1109 (2000) 14. Roy M.C.: Surgical site infections after coronary artery bypass graft surgery. Discriminating site specific risk factors to improve prevention efforts. Infect. Control. Hosp. Epidemiol. 19: 229-233 (1998) 15. Nicolle L.E., Huchcroft S., Ctuse P.J.F.: Risk factors for surgical wound infection among the elderly. J. Clin. Epidemiol. 4: 357-364 (1992) 16. Fasor R, Schindler M, Schumacher B, et al. The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardiovasc Surgeon 40:126-129 (1992) 17. Meller A.M., Villebro N., Pedersen T., Tonnesen H.: Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359: 114-117 (2002) 18. Fietsam R., Bassett J., Clover J.: Complications of coronary artery surgery in diabetic patients. Am. Surg. 57: 551-557 (1991) 19. Sthale E., Tammeln A., Bergstrom R., Nystrom S.O., Hansson H.E.: Sternal wound complications incidence, microbiology and risk factors. Eur. J. Cardiothorac. Surg. 11: 1146-1153 (1997) 20. Blanchard A., Hurni M., Ruchat P., et al.: Incidence of deep and superficial sternal infection after open heart surgery. A ten years retrospective study from 1981 to 1991. Eur. J. Cardiothorac. Surg. 9: 153-157 (1995) 21. Friberg B, Friberg S, Burman LG. Zoned vertical ultraclean operating room ventilation. A novel concept making long side walls unnecessary. Acta Orthoped. 67: 578-582 (1996) 22. Tammelin A., Hambraeus A., Stahle E.: Source and route of methicillin resistant Staphylococcus epidermidis transmitted to the surgical wound during cardio thoracic surgery. Possibility of preventing wound contamination by use of hospital scrub suits. J. Hosp. Infect. 47: 266-276 (2001) 23. Eklund A.M., Ojajarvi J., Latinen K., Valtonen M., Werkkala K.A.: Glove punctures and postoperative skin flora of hands in cardiac surgery. Ann. Thorac. Surg. 74: 149-153 (2002) 24. Koval K.J., Rosenberg A.D., Zukeran J.D., et al.: Does blood transfusion increase the risk of infection after hip fracture? J. Orthopaed. Trauma 11: 260-266 (1997) 25. Horan T.C., Andrus M., Dudeck M.A.: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control. 36: 309-332 (2008) 26. Institute for healthcare improvement: bundle up for safety. http://www.ihiorg/ihi/Topics/Critical Care/ IntensivecRE/ImprovementStories/bundleUpforsafety.htm (accessed Jul. 26, 2006) 27. Segers P., de Jong A.P, Kloek J., et al.: Risk control of surgical site infection after cardiothoracic surgery. J. Hosp. Infect. 81: 403-407 (2006) 28. Scurr U.P., Lachat M.L., Reuthebuch O., et al.: Endoscopic saphenous vein harvesting for CABG-a randomized, prospective trial. Thorac. Cardiovasc. Surg. 50: 160-163 (2002) 29. McConkey S., L’Ecuyer P., Murply D., et al.: Results of a comprehensive infection control program for reducing surgical site infections in coronary artery bypass surgery. Infect. Control. Hosp. Epidemiol. 20: 533-538 (1999) 30. Manian F.A., Lynn M.: Comparison of patient telephone survey with traditional surveillance and monthly physician questionnaires in monitoring surgical wound infections. Infect. Control. Hosp. Epidemiol. 14: 216-218 (1993) 31. Avato J, Kew Lai K. Impact of postdischarge Surveillance on surgical site infection rates for coronary artery bypass procedures. Infect Control Hosp Epidemiol 23: 364-367 (2002) 32. Gandhi R.H., Katz D., Wheeler J.R., et al.: Vein harvest ischaemia: a peripheral vascular complication of coronary artery bypass grafting. Cardiovasc. Surg. 2: 478-483 (1994) 33. El Oakley R., Paul E., Wong P.S., et al.: Mediastinitis in patients undergoing cardiopulmonary bypass: risk analysis and midterm results. J. Cardiovasc. Surg. 38: 595-600 (1998) 34. Ascaso J.F., Arbona C., Alcacer F., et al.: Infection in diabetes: the relation to the degree of metabolic control and protein malnutrition. Med. Clin. 95: 721-724 (1990) 35. Hostetter M.K.: Handicaps to host defence: effects of hyperglycaemia on C3 and Candida alpacas. Diabetes 39: 271-275 (1990) 36. Alexiewicz J.M., Kummar D., Smogorzewski M., Massry S.G.: Elevated Cytosolic calcium and impaired proliferation of B Lymphocytes in type II diabetes mellitus. Am. J. Kidney Dis. 30: 98-104 (1997) 37. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al.: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann. Thorac. Surg. 63: 356-361 (1998) |
|
| Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr |
|